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ABSTRACT
Objective: This study aims to investigate the effects of the Heliotropium indicum extract (HIE) on factor promoting wound healing in radical scavenging 
and inflammatory activity and growth factor promotion.
Methods: The radical scavenging capacity of HIE was evaluated by scavenging of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide (NO) radicals. 
Furthermore, the anti-inflammatory of HIE was determined in a cellular model. RAW264.7 macrophage cells were treated with various concentrations 
of HIE before activating the treated cell with lipopolysaccharide (LPS). The nitrite concentration of activated macrophage was determined by the Griess 
reagent kit. The cell viability of RAW264.7 was evaluated by resazurin reduction assay as well as NIH3T3 fibroblast cells. In addition, production of the 
growth factors (transforming growth factor-β [TGF-β] and basic fibroblast growth factor [bFGF]) of fibroblast was determined by Elisa kit.
Results: HIE exhibited radical scavenging activity in the DPPH and NO radicals with half maximal inhibitory concentration (IC50) at 0.22 mg/ml and 
0.52 mg/ml, respectively. In a cellular study, HIE inhibited NO production in LPS-stimulated macrophage without cytotoxic effect to the cells with IC50 
at 87 µg/ml. Furthermore, HIE promoted fibroblast cell viability at 72 h of treatment and, TGF-β and bFGF production at 24 h of treatment.
Conclusion: These results obtained in this study suggested that HIE promoted the factors which involved in wound healing processes, including anti-
inflammatory effect with scavenged radical forming and inhibited activated-macrophage. Furthermore, HIE also stimulated growth factor production 
in fibroblast. These finding supported using traditional and folk medicine of H. indicum in wound treatment.
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INTRODUCTION
Wound healing is a crucial physiological process that involves in 
communication of multiple cell types. The integration of cellular and 
molecular events occurs after the onset of tissue damage to a restoration 
of the injured tissues. The tissue restoration mechanism is continued 
with overlapping processes by hemostasis, inflammation, proliferation, 
and tissue remodeling [1].
Macrophages and fibroblast play critical roles in all phases of wound 
healing. After tissue injury, macrophages infiltrate to the lesion for 
phagocytosis of bacterial pathogens, foreign debris, and dead cells, and 
generate pro-inflammatory mediators resulting in inflammation [2]. 
In the inflammatory phase, macrophages are called M1 macrophages. 
They are activated to generate reactive oxygen species (ROS) as 
well as nitric oxide (NO) to contribute reactive nitrogen species 
(RNS) for clearance of pathogens and apoptotic cells. In addition, 
macrophages also generate pro-inflammatory mediators, for example, 
interleukin (IL)-1, IL-6, and tumor necrosis factor-α (TNF-α) as well 
as growth factors, for example, basic fibroblast growth factor (bFGF), 
transforming growth factor-β (TGF-β), vascular endothelial growth 
factor (VEGF), and platelet-derived growth factor (PDGF). These 
pro-inflammatory mediators and growth factors recruit endothelial 
cells, keratinocytes, and fibroblasts to heal the injured tissues [3]. In 
the late inflammatory phase, the pro-inflammatory M1 macrophages 
transit to anti-inflammatory M2 macrophages for production of anti-
inflammatory cytokines, for example, IL-4 and IL-10; meanwhile, 
inflammation is subsided let through the proliferative phase. In the 
remodeling phase, macrophages release matrix metalloproteinases to 
break down the temporary extracellular matrix (ECM) [4].
Fibroblasts are recruited to the wound site from the wound edge or the 
bone marrow after wounding. At the inflammation phase, fibroblasts 
produce several chemokines. At the proliferation phase, fibroblasts are 
activated within the wound site and differentiated to myofibroblasts 
to form granulation tissue. Both fibroblasts and myofibroblasts play a 
crucial role in generation of traction and contractile forces, respectively, 
to promote wound closure [5]. Fibroblasts also produce important 
growth factors including TGF-β and bFGF.
TGF-β is implicated in the control of fibroblast proliferation, and 
transformation of fibroblasts into myofibroblasts, production of the ECM, 
stimulation of collagen production, production of elastin, and synthesis 
of fibronectin, and inhibition of ECM degradation [6]. bFGF is also 
involved in the regulation of the replication and migration of epithelial, 
endothelial, and fibroblast cells, which participated in the production of 
collagen, epithelialization, and neovascularization, respectively [7].
In the case of chronic wound, it is found the excess production of ROS 
and RNS, which can directly interact with various biological targets. 
Macrophages are continuously activated to produce ROS, RNS, and 
pro-inflammatory cytokines including IL-1, IL-6, and TNF-α resulting 
in excess of inflammation where accompany with the limitation of 
growth factor, for example, TGF-β and bFGF, production [8]. The 
immoderate inflammation cause an imbalance of the healing processes 
indicated that the proliferative and remodeling phases do not readily 
occur. This event originates chronic wound which does not heal in a 
timely manner [9,10].
Heliotropium indicum is found in many paths of the world such as India, 
Africa, Bangladesh, Sri Lanka, Nepal, the Philippines, and Thailand. It has 
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been used to cure various diseases in different traditional and folklore 
medicine system. In folk remedies, H. indicum has been used for treating 
fever, insect bite, diarrhea, skin rash, and herpes as well as wound 
and ulcer [11]. Furthermore, it has been reported that the application 
of the leaf paste of H. indicum to heal rheumatism and skin infections 
as well as fresh cuts and wounds [12]. Previous studies in the animal 
model reported the healing promotion of H. indicum extract (HIE) in the 
incision and infected wound [12] as well as diabetic wound [13].
This study aims to examine the HIE on the factor promoting wound 
healing including (a) in vitro radical scavenging activity, (b) anti-
inflammatory activity in macrophage, (c) production of growth factors 
(TGF-β1 and bFGF) in fibroblast, and (d) viability of macrophage 
and fibroblast cells. These results provide scientific support of using 




H. indicum Linn. procured from Khaen Dong District, Buri Ram Province, 
Northeastern Thailand. The leaves of the plant were cleaned with 
water then dried at 50°C for 72 h. The dried plant was grounded and 
stored at room temperature in vacuum. The extract was prepared by 
maceration of the grounded plant in 70% ethanol and shook at 250 rpm 
with the shaker for 24 h. The macerated mixture was filtrated for 
collected supernatant to evaporate at 50°C for 24 h. The crude extract 
of H. indicum leaves was stored at −20°C until used.
2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity 
of HIE
The HIE was first dissolved in a 2% dimethyl sulfoxide (DMSO), 
approximately 75 µl of the dissolved HIE of variable concentrations 
(0.0156, 0.0312, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg/ml) was 
mixed with 150 µl of 0.2 mM DPPH (Sigma-Aldrich USA) solution (in 
methanol) and allowed to stand for 30 min without direct exposure to 
light. The absorbance was determined at 520 nm using a microplate 
reader. In addition, DMSO and L-ascorbic acid were used as negative 
and positive controls, respectively. The DPPH scavenging capacity of 
the experimental HIE is presented as a percentage of DPPH radical 
inhibition as below, where OD is the optical density:
without  extract with extract
without  extract





NO radical scavenging of HIE
In this research, sodium nitroprusside (SNP) (Sigma-Aldrich, USA) 
was utilized as the NO donor. Specifically, 10 mM of SNP in a pH7.4 
PBS solution was incubated with 1 ml dissolved HIE of variable 
concentrations (0.0156, 0.0312, 0.0625, 0.125, 0.25, 0.5, 1, and 2 mg/ml) 
at 25°C for 180 min. Approximately 100 µl of the resulting solution was 
withdrawn to react with a Griess Reagent kit (Promega, USA) whereby 
the solution was reacted with 20 µl sulfanilamide for 10 min and then 
20 µl N-1-naphthylethylenediamine dihydrochloride for another 10 min. 
The reaction mixture absorbance was measured at 560 nm, and the NO 
concentrations were determined as the nitrite (NO2-) concentrations 
from the standard curve of a standard nitrite solution. The reaction 
mixture absorbance was measured at 560 nm. DMSO and L-ascorbic 
acid were used as negative and positive controls, respectively. The 
NO scavenging capacity of the experimental pectin is expressed as a 
percentage of nitrite production inhibition using the following formula:
2 without  extract 2 with extract
2
2 without  extract








RAW264.7 murine macrophage and NIH3T3 murine fibroblast 
cell line were obtained from the American Type Culture Collection 
(ATCC, Manassas, VA). The cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) (Gibco, USA) containing 10% fetal 
bovine serum (Gibco, USA) and 100 U/ml penicillin and 100 µg/ml 
streptomycin (Gibco, USA) and incubated at 37°C in 5% CO2/95% air 
humidified incubator. The RAW264.7 cell was subcultured using cell 
scraper twice a week, and 3T3 cell was subcultured using 0.25% trypsin-
EDTA (Gibco, USA) trypsinization. The cell viability was determined 
using 0.4% trypan blue (Sigma-Aldrich, USA) with cell viability >85% 
and was used in all the experiments.
NO production in the lipopolysaccharide (LPS)-stimulated 
macrophage
The RAW264.7 macrophage cells (2×105 cell/ml) were pretreated 
with the dissolved HIE of variable concentrations (6.25, 12.5, 25, 
50, and 100 µg/ml) in a 96-well plate and incubated at 37°C for 
24 h. The pre-treated cells were stimulated with 1 µg/ml of LPS and 
incubated for another 24 h. The NO concentrations were determined 
from nitrite (NO2-) in the stimulated-cell supernatant using a Griess 
Reagent Kit whereby 100 µl of the supernatant was reacted with 20 µl 
sulfanilamide for 10 min and with 20 µl N-1-naphthylethylenediamine 
dihydrochloride for another 10 min. The reaction mixture absorbance 
was measured at 560 nm, and the NO concentrations were determined 
as the nitrite (NO2-) concentrations from the standard curve of 
a standard nitrite solution. About 0.2% DMSO and 100 µM of 
dexamethasone each with 1 µg/ml LPS were, respectively, used as the 
negative and positive controls.
Determination of cell viability of RAW264.7 macrophage cells
The viability of the residual macrophage cells after the NO assay, 
given HIE concentrations of 6.25, 12.5, 25, 50, and 100 µg/ml, was 
examined by resazurin (Sigma-Aldrich, USA) reduction assay, whereby 
the residual cells were incubated for 2 h at 37°C in 100 µl fresh DMEM 
containing 50 µg/ml resazurin. The reaction mixture absorbance was 
determined at 560 against 600 nm. The cell viability of the RAW264.7 
macrophage cells was presented as percentage cell viability using the 
following formula:
( )
560 600 with extract
560 600 without  extract





Determination of cell viability of NIH3T3 fibroblast cells
The NIH3T3 fibroblast cells (4×105 cell/ml) were seeded in a 96-well 
plate and incubated at 37°C for 24 h. The cells were treated with the 
variable of HIE concentrations at 6.25, 12.5, 25, 50, and 100 µg/ml 
for 24, 48, and 72 h. The cell viability was determined by resazurin 
(Sigma-Aldrich, USA) reduction assay, whereby the cells were incubated 
for 4 h at 37°C in 100 µl fresh DMEM containing 50 µg/ml resazurin. 
The reaction mixture absorbance was determined at 560 against 
600 nm. The cell viability of the NIH3T3 fibroblast cells was presented 
as percentage cell viability using the above formula.
TGF-β and bFGF production in fibroblast cells
The NIH3T3 fibroblast cells (4×105 cell/ml) were seeded into 24-well 
plate at 37°C for 24 h. The cells were treated with the variable of 
HIE concentration at 12.5, 25, and 50 µg/ml for another 24 h. The 
supernatant was collected to determine TGF-β and bFGF levels, 
respectively, using TGF-β1 Mouse Elisa kit (Abcam, USA) and bFGF 
Mouse Elisa kit (Sigma-Aldrich, USA) according to the manufacturer’s 
protocol.
Statistical analysis
In this study, data from at least three independent experiments 
carried out in triplicate. The statistical data were expressed as mean 
with a standard error of the mean. The negative control group was 
compared against the experimental group using one-way ANOVA with 
Tukey’s honestly significant difference (HSD) post hoc test, with the 5% 
(*p<0.05) and 1% (**p<0.01) significance level.
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RESULTS
DPPH scavenging capacity of HIE
In this study, the DPPH scavenging capacity of HIE is evaluated by 
the percentage of DPPH free radical inhibition and half maximal 
inhibitory concentration (IC50). IC50 is the IC at which the DPPH 
radicals are scavenged by 50%. The results revealed that with 
0.0156–2 mg/ml (0.0156, 0.0312, 0.0625, 0.125, 0.25, 0.5, 1, and 
2 mg/ml) of HIE concentrations, HIE significantly reduces DPPH 
radicals, achieving the inhibition performance in the range of 
29.17±5.62–90.78±1.17% (Fig. 1); and an IC50 of 0.22 mg/ml. Meanwhile, 
L-ascorbic acid at the same concentration which used as the positive 
control exhibits the inhibition efficiency of 31.53±3.90–84.88±0.29% 
(Fig. 1); and an IC50 of 0.030 mg/ml (Table 1).
NO scavenging capacity of HIE
The experimental results reveal that HIE could scavenge the NO radicals. 
In the negative control with the absence of HIE (DMSO) presented a 
high nitrite (a stable product of NO) concentration while the positive 
control (L-ascorbic acid) inhibited the nitrite (NO2-) formation. The 
resulted revealed that with 0.0156–2 mg/ml (0.0156, 0.0312, 0.0625, 
0.125, 0.25, 0.5, 1, and 2 mg/ml) of HIE concentrations, HIE significantly 
reduces NO2- formation, achieving the scavenging performance in the 
range of 3.59±0.46–66.61±2.87% (Fig. 1); and an IC50 of 0.52 mg/ml 
(Table 1), where IC50 is the IC at which the NO radicals are scavenged 
by 50%. By comparison, L-ascorbic acid (the positive control) at 
the same concentrations achieved the inhibition performance of 
32.26±0.86–91.72±0.19% (Fig. 1); and an IC50 of 0.034 mg/ml (Table 1).
Effect of HIE on NO production and cell viability in LPS-stimulated 
macrophage
In this study, the RAW264.7 macrophage cells were treated with variable 
concentrations of HIE (6.25, 12.5, 25, 50, and 100 µg/ml) for 24 h 
before activating with 1 µg/ml LPS. Furthermore, DMSO and 100 µM of 
dexamethasone each with LPS were, respectively, used as the negative 
and positive controls. In Fig. 2a, the experimental results showed that 
the nitrite (NO2-) concentration in the LPS-stimulated macrophage was 
decreased in HIE-treated cells, achieving the inhibition performance in 
the range of 16.64±1.70–54.87±1.86% (Fig. 2a); and an IC50 of 87 µg/ml. 
The NO inhibition is more obvious in the treatment with 12.5–100 µg/ml 
HIE concentrations. The dexamethasone-treated cells (positive control) 
achieved NO inhibition performance by 64.51±6.63% (Fig. 2a).
In Fig. 2b, the viability of the RAW264.7 macrophage cells was assessed 
by a resazurin reduction assay and the effective HIE concentrations 
determined. DMSO and dexamethasone each with 1 µg/ml LPS were, 
respectively, used as the negative and positive controls. In general, the 
cell viability and NO production are positively correlated. Given the 
non-cytotoxicity of HIE, the HIE-treated cells could achieve high NO 
inhibition performance with no effect to cell viability.
Effect of HIE on fibroblast cell viability
The cell viability of the NIH3T3 fibroblast cells was examined by resazurin 
reduction assay. DMSO was used as negative control. In Fig. 3, the fibroblast 
cells were treated with variable concentration of HIE 6.25–100 µg/ml. 
The results indicate that the cell viability of HIE-treated cell for 24, 48, 
and 72 h trend to increase. However, the cell viability of 24 and 48 h of 
treatment was not significantly different from the control (DMSO treated-
Table 1: DPPH and NO half maximal inhibitory concentrations of 
HIE and L-ascorbic acid




L-ascorbic acid 0.030 0.034
DPPH: 2,2-diphenyl-1-picrylhydrazyl, NO: Nitric oxide, 
HIE: Heliotropium indicum extract, IC50: Half maximal inhibitory 
concentration
Fig. 1: The nitric oxide (nitrite) inhibition efficiency (%) under 
variable Heliotropium indicum extract (HIE) and L-ascorbic acid 
concentrations, compared with HIE-free dimethyl sulfoxide (the 
negative control). The values are means ± standard error of the 
mean. L-ascorbic acid is used as the positive control
Fig. 2: Effect of variable Heliotropium indicum extract concentration in 1 µg/ml lipopolysaccharide-stimulated RAW264.7 
macrophage: (a) Percentage of nitric oxide inhibition, (b) cell viability. The values are means ± standard error of the mean. **denote 
p<0.01. Dimethyl sulfoxide and dexamethasone are, respectively, used as negative and positive controls
a b
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cells). For 72 h of HIE-treated cells, the cell viability is more pronounced in 
treatment with 50 µg/ml HIE concentration-treated cell (Fig. 3).
Effect of HIE on TGF-β1 and bFGF production in fibroblast cells
The growth factors, TGF-β1, and bFGF are determined by ELISA kit. The 
results exhibited that HIE with a concentration of 12.5, 25, and 50 µg/ml 
significantly increase the production of TGF-β1 (Fig. 4a) and bFGF (Fig. 4b).
DISCUSSION
Wound healing is the coordination and dynamic process that 
involves in many cell types, including macrophages and fibroblasts 
as well as their cytokines and growth factors. Macrophages promote 
and resolute inflammation, remove apoptotic or debris cells, and 
support cell proliferation, which makes equable of wound healing 
process [14]. However, macrophages have the potential to disturb 
different phases of repair, and persistent macrophage activation can 
lead to maladaptive, chronic inflammation, and dysfunction wound 
healing [15]. Macrophages continue to produce NO and ROS in 
prolonging inflammation that can cause to wound surrounding cell 
injury and chronic wound [16]. The previous study demonstrated that 
the chronic wound both infected and noninfected wounds improved by 
antioxidant, where it scavenges the excess free radicals to reduce the 
damage caused. In addition, the previous study revealed the correlation 
of radical scavenging properties of Sphaeranthus amaranthoides and 
wound healing improvement in mice [17]. This current study showed 
that HIE effectively scavenged free radical, DPPH, and NO. Based 
on these results, radical scavenging activity of HIE belongs to the 
enhancement of wound healing.
Moreover, the results also revealed the anti-inflammatory property of 
HIE through inhibition of NO production in activated macrophages. In 
general, although NO is a physiological signaling molecule, inordinate 
inducible NO becomes oxidative molecule which can interact with O2- to 
produce cytotoxic oxidant peroxynitrite (ONOO-). The peroxynitrite is 
a powerful oxidant initiate cleavage DNA resulting in cell damage [18]. 
Prolong activation of macrophages cause to continue production of 
NO associated with chronic inflammation that impedes proliferation 
stage in the wound healing process [19]. The previous study revealed 
that failure in the change of M1 inflammatory macrophage to M2 anti-
inflammatory macrophage phenotype caused to prolong inflammatory 
stage of wound healing where delay in transition to the proliferative 
stage [20]. Furthermore, suppression of M1 inflammatory macrophage 
and enhancement of M2 anti-inflammatory macrophage polarization 
together with degradation of receptor interacting protein 140 became 
anti-inflammation to promote diabetic chronic wound healing 
in mice [21]. In this study, HIE inhibited the production of NO in 
activated macrophage and given non-cytotoxic to the cells, suggested 
that the limitation of inflammation, where to support the initiation of 
proliferation stage of wound healing.
Proliferative stage of wound healing occurs after the subsidence of 
inflammation where the major focus on re-epithelialization, vascular 
network restoration, and granulation tissue formation. Fibroblasts play 
important roles to form the granulation tissue. They migrate from the 
nearby dermis to the wound in response to cytokines and growth factors 
produced by platelets and macrophages in the wounds, for example, 
PDGF, TGF-β, and bFGF. In addition, fibroblasts also produce cytokines, 
chemokines, and growth factors to enhance angiogenesis [22]. bFGF 
and TGF-β1 are key growth factors implicating in the process of wound 
healing.
In this study, TGF-β1 and bFGF were upregulated in HIE-treated 
fibroblast cells. The previous study demonstrated that aloe vera 
can stimulate TGF-β1 and bFGF production in mouse embryonic 
fibroblast cell [23] as well as Panax ginseng encouraged TGF-β1, 
collagen type I, and VEGF production in NIH3T3 fibroblast cells [24]. 
These growth factors are important in the improvement of chronic 
wound healing. TGF-β1 regulates several cell functions, for example, 
proliferation, differentiation, apoptosis, cell adhesion, cell motility, 
and ECM production [25]. bFGF regulates replication and migration of 
epithelial, endothelial, and fibroblast cells which implicated in collagen 
production, epithelialization, and neovascularization of the wound 
healing process [26]. The upregulation of these growth factors in 
Fig. 3: The effects of variable Heliotropium indicum extract 
concentrations treated cell for 24, 48, and 72 h on cell viability 
of NIH3T3 fibroblast cells. The values are mean ± standard error 
of the mean. *denote p<0.05. 0.2% dimethyl sulfoxide is used as 
negative control
Fig. 4: The effects of variable Heliotropium indicum extract concentrations treated cell for 24 h on growth factor production in NIH3T3 
fibroblast cells: (a) Transforming growth factor-β1, (b) basic fibroblast growth factor. The values are mean ± standard error of the mean. 
*and **, respectively, denote p<0.05 and p<0.01. 0.2% dimethyl sulfoxide is used as negative control
a b
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function and production can help wound repair, especially the chronic 
wounds which presented growth factor deficiency.
In an animal model study, HIE promoted the healing of excision (normal 
and infected), incision, and dead space wound models [12], and excision 
wound in streptozotocin-induced diabetic rats [13]. The findings from 
our research in the cellular study provide a better understanding of 
the function of HIE in wound healing improvement. Given antioxidant, 
anti-inflammatory properties, and growth factors promotion of HIE, 
the extract could thus be applied to encourage chronic wound healing 
and increase the possibility of therapeutic application of HIE in wound 
healing. However, further phytochemical studies of HIE are required to 
separate the active compounds responsible for these pharmacological 
activities.
CONCLUSION
This experimental research has investigated the scavenging ability 
of HIE of variable concentration (0.0156–2 mg/ml) on DPPH and 
NO free radicals; anti-inflammatory property through inhibition of 
NO production in LPS-stimulated macrophage cells; and cell viability 
of LPS-stimulated macrophage and fibroblast cells, given the HIE 
concentration 6.25–100 µg/ml; and promotion of TGF-β1and bFGF 
growth factors in fibroblast cells, given the HIE concentrations of 
12.5–50 µg/ml. The experimental results revealed that the DPPH and 
NO scavenging performance and the HIE concentration are positively 
correlated, with the corresponding IC50 of 0.22 and 0.52 mg/ml. In 
addition, inhibition of NO production in LPS-stimulated RAW264.7 
macrophage cells is also positively correlated to the HIE concentrations 
with no effect to cell viability. The experimental results also revealed that 
the cell viability of fibroblast trend to increase in 72 h of HIE treatment. 
Moreover, the results also presented the promotion of TGF-β1and bFGF 
growth factors production in HIE-treated fibroblast cells. The findings 
demonstrate the benefit of HIE in wound healing promotion.
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